Loading...
Structural determinants for small-molecule activation of skeletal muscle AMPK α2β2γ1 by the glucose importagog sc4
Ngoei, Kevin R.W. Langendorf, Christopher G. Ling, Naomi Hoque, Ashfaqul Johnson, Swapna Camerino, Michelle C. Walker, Scott R. Bozikis, Ylva E. Dite, Toby A. Ovens, Ashley J.
Ngoei, Kevin R.W.
Langendorf, Christopher G.
Ling, Naomi
Hoque, Ashfaqul
Johnson, Swapna
Camerino, Michelle C.
Walker, Scott R.
Bozikis, Ylva E.
Dite, Toby A.
Ovens, Ashley J.
Author
Ngoei, Kevin R.W.
Langendorf, Christopher G.
Ling, Naomi
Hoque, Ashfaqul
Johnson, Swapna
Camerino, Michelle C.
Walker, Scott R.
Bozikis, Ylva E.
Dite, Toby A.
Ovens, Ashley J.
Smiles, William
Jacobs, Roxane
Huang, He
Parker, Michael W.
Scott, John W.
Rider, Mark H.
Foitzik, Richard C.
Kemp, Bruce
Baell, Jonathan B.
Oakhill, Jonathan S.
Langendorf, Christopher G.
Ling, Naomi
Hoque, Ashfaqul
Johnson, Swapna
Camerino, Michelle C.
Walker, Scott R.
Bozikis, Ylva E.
Dite, Toby A.
Ovens, Ashley J.
Smiles, William
Jacobs, Roxane
Huang, He
Parker, Michael W.
Scott, John W.
Rider, Mark H.
Foitzik, Richard C.
Kemp, Bruce
Baell, Jonathan B.
Oakhill, Jonathan S.
Abstract
The AMP-activated protein kinase (AMPK) αβγ heterotrimer regulates cellular energy homeostasis with tissue-specific isoform distribution. Small-molecule activation of skeletal muscle α2β2 AMPK complexes may prove a valuable treatment strategy for type 2 diabetes and insulin resistance. Herein, we report the small-molecule SC4 is a potent, direct AMPK activator that preferentially activates α2 complexes and stimulates skeletal muscle glucose uptake. In parallel with the term secretagog, we propose “importagog” to define a substance that induces or augments cellular uptake of another substance. Three-dimensional structures of the glucose importagog SC4 bound to activated α2β2γ1 and α2β1γ1 complexes reveal binding determinants, in particular a key interaction between the SC4 imidazopyridine 4′-nitrogen and β2-Asp111, which provide a design paradigm for β2-AMPK therapeutics. The α2β2γ1/SC4 structure reveals an interaction between a β2 N-terminal α helix and the α2 autoinhibitory domain. Our results provide a structure-function guide to accelerate development of potent, but importantly tissue-specific, β2-AMPK therapeutics. Therapeutic activation of the metabolic regulator AMPK in skeletal muscle is a validated strategy to combat type 2 diabetes. Ngoei et al. have solved the crystal structure of the activator SC4complexed to a skeletal muscle AMPK isoform, identifying important binding determinants that will advance development of AMPK-targeting therapeutics.
Keywords
AMP-activated protein kinases, diabetes, drug development, glucose disposal, importagog, metabolism, secretagog, X-ray crystallography
Date
2018
Type
Journal article
Journal
Cell Chemical Biology
Book
Volume
25
Issue
6
Page Range
728-737
Article Number
ACU Department
Mary MacKillop Institute for Health Research
Faculty of Health Sciences
Faculty of Health Sciences
Collections
Relation URI
Source URL
Event URL
Open Access Status
License
File Access
Controlled